Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2005-05-13 | Mr. Drapkin was a partner in the law firm of Skadden, Arps, Slate, Meagher & Flom LLP for more than five years. |
| 2006-05-01 | Mr. Drapkin was a partner in the law firm of Skadden, Arps, Slate, Meagher & Flom LLP for more than five years. |
| Filing Date | Source Excerpt |
|---|---|
| 2001-07-31 | Donald G. Drapkin has served as Chairman of the Board and a Director of Siga since April 19, 2001. Mr. Drapkin has been a Director and Vice Chairman of MacAndrews & Forbes Holdings Inc. and various of its affiliates since 1987. Prior to joining MacAndrews & Forbes, Mr. Drapkin was a partner in the law firm of Skadden, Arps, Slate, Meagher & Flom LLP for more than five years. Mr. Drapkin is also a Director of the following corporations which file reports pursuant to the Securities Exchange Act of 1934: Anthracite Capital, Inc.; Black Rock Asset Investors; Genta Inc.; The Molson Companies Limited; Panavision, Inc.; Playboy Enterprises, Inc.; Playboy.com, Inc.; ProxyMed, Inc.; Revlon Consumer Products Corporation; Revlon, Inc.; The Warnaco Group, Inc.; and Weider Nutrition International Inc. During fiscal year 2000, no fees were paid to directors, and no directors were reimbursed for expenses incurred. Subject to the approval of the amendment and restatement of Siga's Amended 1996 Incentive and Non-Qualified Stock Option Plan (the "Option Plan") by our stockholders (Proposal 3 to be voted upon at the meeting to which this Proxy Statement relates), Siga has granted options ("Contingent Options") to purchase shares of Siga common stock to its directors under that plan. The number of shares for which each director has been granted Contingent Options is set forth in parentheses after his name: Donald G. Drapkin (1,125,000). The exercise price for each Contingent Option will be $2.50, the fair market value at the date of grant, and all Contingent Options will be immediately exercisable upon approval of the amendment and restatement of the Option Plan. |
| 2002-11-07 | Donald G. Drapkin has served as Chairman of the Board and a Director of SIGA since April 19, 2001. Mr Drapkin has been a Director and Vice Chairman of MacAndrews & Forbes Holdings Inc. and various of its affiliates since 1987. Prior to joining MacAndrews & Forbes, Mr. Drapkin was a partner in the law firm of Skadden, Arps, Slate, Meagher & Flom LLP for more than five years. |
| 2003-12-05 | Donald G. Drapkin 55 Chairman of the Board of Directors Donald G. Drapkin has served as Chairman of the Board and a director of SIGA since April 19, 2001. |
| 2004-11-22 | Donald G. Drapkin* 56 Chairman of the Board * Determined by the Board of Directors to be independent pursuant to Rule 4200 of the NASD Marketplace Rules. Donald G. Drapkin has served as Chairman of the Board and a director of SIGA since April 19, 2001. Mr. Drapkin has been Vice Chairman and a director of MacAndrews & Forbes Holdings Inc. and various of its affiliates since 1987. Prior to joining MacAndrews & Forbes, Mr. Drapkin was a partner in the law firm of Skadden, Arps, Slate, Meagher & Flom LLP for more than five years. Mr. Drapkin is also a director of the following corporations which file reports pursuant to the Securities Exchange Act of 1934: Anthracite Capital, Inc., , Playboy Enterprises, Inc., Revlon Consumer Products Corporation, Revlon Inc. and Nephros, Inc. Mr. Drapkin is also a director of PharmaCore, Inc. and TransTech Pharma, Inc. ... It is anticipated that after the Annual Meeting Donald G. Drapkin, Paul G. Savas and Mehmet C. Oz will be appointed to serve on the Compensation Committee. |
| 2005-04-29 | Donald G. Drapkin has served as Chairman of the Board and a director of SIGA since April 19, 2001. Mr. Drapkin has been Vice Chairman and a director of MacAndrews & Forbes Holdings Inc. and various of its affiliates since 1987. Prior to joining MacAndrews & Forbes, Mr. Drapkin was a partner in the law firm of Skadden, Arps, Slate, Meagher & Flom LLP for more than five years. Mr. Drapkin is also a director (or member of the board of managers, as applicable) of the following corporations which file reports pursuant to the Securities Exchange Act of 1934: Allied Security Holdings, LLC, Anthracite Capital, Inc., Nephros, Inc, Playboy Enterprises, Inc., Revlon Consumer Products Corporation and Revlon Inc. Mr. Drapkin is also a director of PharmaCore, Inc. and TransTech Pharma, Inc. |
| 2006-11-20 | Donald G. Drapkin has served as Chairman of the Board and a director of SIGA since April 19, 2001. Mr. Drapkin has been Vice Chairman and a director of MacAndrews & Forbes Holdings Inc. and various of its affiliates since 1987. ... The Compensation Committee, which currently consists of directors Donald G. Drapkin, Paul G. Savas and Mehmet C. Oz, held one meeting during 2005. ... Directors who are not currently receiving compensation as officers or employees of the Company or any of its affiliates receive $1,000 per meeting for board meetings ... |
| Filing Date | Source Excerpt |
|---|---|
| 2012-04-03 | Donald G. Drapkin 64 Director of the Company since March 3, 2011. Founder and Chairman of Casablanca Capital, LLC since 2010. ... The following table shows the total compensation for our non-employee directors for the fiscal year ended December 31, 2011: Donald G. Drapkin 2011 30,000 131,850 --- 3,000 164,850 |
| 2013-04-03 | Donald G. Drapkin, 65, Director of the Company since March 3, 2011. Founder and Chairman of Casablanca Capital, LLC since 2010. Vice Chairman of Lazard International, a global advisory investment bank, and Chairman of Lazard's Investment Committee from 2007 to 2010. Vice Chairman of MacAndrews & Forbes Holdings, Inc., a holding company with interests in a diversified portfolio of public and private companies, and various of its affiliates from 1987 to 2007. Previously a partner in the law firm of Skadden, Arps, Slate, Meagher & Flom, LLP. Mr. Drapkin is also a member of the American Bar Association and the New York City Bar Association. Mr. Drapkin has demonstrated knowledge of highly sophisticated securities transactions, which he garnered over his 30 plus years of collective executive, management and legal expertise and which the Board expects will be valuable to the Company when it considers financing options and the deployment of its capital. Director Compensation Table: Donald G. Drapkin, 2012, Fees Earned or Paid In cash: $50,000, Share Awards: $147,500, All Other Compensation: $5,916, Total: $203,416. |
| 2014-04-04 | Donald G. Drapkin 66 Director of the Company since March 3, 2011. ... The table below shows current membership for each of the standing committees. Audit Committee Donald G. Drapkin The following table shows the total compensation for our non-employee directors for the fiscal year ended December 31, 2013: Donald G. Drapkin 2013 50,000 180,250 --- 7,799 238,049 |
| 2015-04-02 | Donald G. Drapkin Age 67 Director since March 3, 2011 Founder and Chairman of Casablanca Capital, LLC Committees: Audit, Nominating & Corporate Governance (Chair) Director of the Company since March 3, 2011. Founder and Chairman of Casablanca Capital, LLC since 2010. The annual compensation to the non-employee directors for 2014 was set and approved by the Board based on the recommendations of, and a peer group analysis performed by, compensation consultants engaged by the Compensation Committee. During 2014, our non-employee directors, other than Mr. Citrin and Mr. Africk, were paid annual cash compensation of $50,000. Mr. Drapkin deferred all of his cash and equity compensation in 2014 pursuant to our Director Deferred Share Program. Mr. Drapkin received 7,001.81 deferred shares in connection with 2014 cash and equity compensation he elected to defer, including deferred shares earned from dividend reinvestment. The following table shows the total compensation for our non-employee directors for the fiscal year ended December 31, 2014: Donald G. Drapkin 2014 $57,500 $169,100 $8,324 $234,924 |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22